219 related articles for article (PubMed ID: 19081017)
1. Treatment of liver ischemia-reperfusion injury by limiting thrombospondin-1/CD47 signaling.
Isenberg JS; Maxhimer JB; Powers P; Tsokos M; Frazier WA; Roberts DD
Surgery; 2008 Nov; 144(5):752-61. PubMed ID: 19081017
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation.
Isenberg JS; Shiva S; Gladwin M
Nitric Oxide; 2009 Aug; 21(1):52-62. PubMed ID: 19481167
[TBL] [Abstract][Full Text] [Related]
3. Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts.
Isenberg JS; Pappan LK; Romeo MJ; Abu-Asab M; Tsokos M; Wink DA; Frazier WA; Roberts DD
Ann Surg; 2008 Jan; 247(1):180-90. PubMed ID: 18156939
[TBL] [Abstract][Full Text] [Related]
4. Thrombospondin-1 regulates blood flow via CD47 receptor-mediated activation of NADPH oxidase 1.
Csányi G; Yao M; Rodríguez AI; Al Ghouleh I; Sharifi-Sanjani M; Frazziano G; Huang X; Kelley EE; Isenberg JS; Pagano PJ
Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2966-73. PubMed ID: 23087362
[TBL] [Abstract][Full Text] [Related]
5. Age-associated induction of cell membrane CD47 limits basal and temperature-induced changes in cutaneous blood flow.
Rogers NM; Roberts DD; Isenberg JS
Ann Surg; 2013 Jul; 258(1):184-91. PubMed ID: 23275312
[TBL] [Abstract][Full Text] [Related]
6. Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation.
Bauer EM; Qin Y; Miller TW; Bandle RW; Csanyi G; Pagano PJ; Bauer PM; Schnermann J; Roberts DD; Isenberg JS
Cardiovasc Res; 2010 Dec; 88(3):471-81. PubMed ID: 20610415
[TBL] [Abstract][Full Text] [Related]
7. Blocking thrombospondin-1 signaling via CD47 mitigates renal interstitial fibrosis.
Julovi SM; Sanganeria B; Minhas N; Ghimire K; Nankivell B; Rogers NM
Lab Invest; 2020 Sep; 100(9):1184-1196. PubMed ID: 32366943
[TBL] [Abstract][Full Text] [Related]
8. CD47 regulates renal tubular epithelial cell self-renewal and proliferation following renal ischemia reperfusion.
Rogers NM; Zhang ZJ; Wang JJ; Thomson AW; Isenberg JS
Kidney Int; 2016 Aug; 90(2):334-347. PubMed ID: 27259369
[TBL] [Abstract][Full Text] [Related]
9. Activation of parenchymal CD47 promotes renal ischemia-reperfusion injury.
Rogers NM; Thomson AW; Isenberg JS
J Am Soc Nephrol; 2012 Sep; 23(9):1538-50. PubMed ID: 22859854
[TBL] [Abstract][Full Text] [Related]
10. Gene silencing of CD47 and antibody ligation of thrombospondin-1 enhance ischemic tissue survival in a porcine model: implications for human disease.
Isenberg JS; Romeo MJ; Maxhimer JB; Smedley J; Frazier WA; Roberts DD
Ann Surg; 2008 May; 247(5):860-8. PubMed ID: 18438125
[TBL] [Abstract][Full Text] [Related]
11. Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling.
Isenberg JS; Frazier WA; Krishna MC; Wink DA; Roberts DD
Curr Drug Targets; 2008 Oct; 9(10):833-41. PubMed ID: 18855617
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondin-1/CD47 blockade following ischemia-reperfusion injury is tissue protective.
Maxhimer JB; Shih HB; Isenberg JS; Miller TW; Roberts DD
Plast Reconstr Surg; 2009 Dec; 124(6):1880-1889. PubMed ID: 19952644
[TBL] [Abstract][Full Text] [Related]
13. Blocking thrombospondin-1/CD47 signaling alleviates deleterious effects of aging on tissue responses to ischemia.
Isenberg JS; Hyodo F; Pappan LK; Abu-Asab M; Tsokos M; Krishna MC; Frazier WA; Roberts DD
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2582-8. PubMed ID: 17916772
[TBL] [Abstract][Full Text] [Related]
14. Increasing survival of ischemic tissue by targeting CD47.
Isenberg JS; Romeo MJ; Abu-Asab M; Tsokos M; Oldenborg A; Pappan L; Wink DA; Frazier WA; Roberts DD
Circ Res; 2007 Mar; 100(5):712-20. PubMed ID: 17293482
[TBL] [Abstract][Full Text] [Related]
15. CD47 blockade alleviates acute rejection of allogeneic mouse liver transplantation by reducing ischemia/reperfusion injury.
Li DY; Xie SL; Wang GY; Dang XW
Biomed Pharmacother; 2020 Mar; 123():109793. PubMed ID: 31884341
[TBL] [Abstract][Full Text] [Related]
16. CD47 blockade reduces ischemia-reperfusion injury and improves outcomes in a rat kidney transplant model.
Lin Y; Manning PT; Jia J; Gaut JP; Xiao Z; Capoccia BJ; Chen CC; Hiebsch RR; Upadhya G; Mohanakumar T; Frazier WA; Chapman WC
Transplantation; 2014 Aug; 98(4):394-401. PubMed ID: 24983310
[TBL] [Abstract][Full Text] [Related]
17. Thrombospondin-1 and CD47 signaling regulate healing of thermal injury in mice.
Soto-Pantoja DR; Shih HB; Maxhimer JB; Cook KL; Ghosh A; Isenberg JS; Roberts DD
Matrix Biol; 2014 Jul; 37():25-34. PubMed ID: 24840925
[TBL] [Abstract][Full Text] [Related]
18. Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses.
Isenberg JS; Annis DS; Pendrak ML; Ptaszynska M; Frazier WA; Mosher DF; Roberts DD
J Biol Chem; 2009 Jan; 284(2):1116-25. PubMed ID: 19004835
[TBL] [Abstract][Full Text] [Related]
19. Activated CD47 regulates multiple vascular and stress responses: implications for acute kidney injury and its management.
Rogers NM; Yao M; Novelli EM; Thomson AW; Roberts DD; Isenberg JS
Am J Physiol Renal Physiol; 2012 Oct; 303(8):F1117-25. PubMed ID: 22874763
[TBL] [Abstract][Full Text] [Related]
20. CD47 blockade reduces ischemia/reperfusion injury in murine heart transplantation and improves donor heart preservation.
Li G; Chen J; Wang Z; Kang S; Liu Y; Ai X; Wang C; Jiang S
Int Immunopharmacol; 2024 May; 132():111953. PubMed ID: 38599097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
